|
|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
5R01CA182284-04
|
$346,525
|
$346,525
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Markers of Cognitive Decline During Treatment for Childhood ALL
|
5R21CA187226-02
|
$215,938
|
$215,938
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
3P30CA013330-44S1
|
$199,871
|
$15,990
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
3P30CA013330-44S2
|
$199,989
|
$15,999
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
3P30CA013330-44S3
|
$500,000
|
$40,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
5P30CA013330-44
|
$3,746,138
|
$299,691
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Osteosarcoma: Patient Derived Xenograft Preclinical Testing
|
5U01CA199221-03
|
$260,103
|
$260,103
|
GORLICK, RICHARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
|
5R01CA191077-02
|
$312,244
|
$312,244
|
NAPPER, ANDREW
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
|
Nemours NCI Community Oncology Research Program (NCORP)
|
5UG1CA189958-03
|
$992,500
|
$992,500
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-03
|
$730,000
|
$182,500
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-02
|
$496,121
|
$496,121
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
SPORE in Lymphoma
|
3P50CA126752-10S1
|
$300,703
|
$33,077
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Enhancing T Cell Therapy of Cancer
|
4P01CA094237-14
|
$1,932,287
|
$483,072
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
SPORE in Lymphoma
|
4P50CA126752-10
|
$2,344,258
|
$257,868
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
4R01CA164024-04
|
$309,159
|
$309,159
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
5R01CA187202-03
|
$102,827
|
$102,827
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
5R01CA185402-03
|
$322,828
|
$322,828
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models
|
5U01CA199288-02
|
$578,693
|
$578,693
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
|
2R01CA116548-11A1
|
$249,637
|
$249,637
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$21,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$30,761
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$21,398
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$89,990
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$24,160
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$585,561
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Pediatric Oncology Clinical Research Training Program
|
4K12CA090433-15
|
$805,190
|
$805,190
|
POPLACK, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-03
|
$402,343
|
$402,343
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
|
5R01CA174808-03
|
$326,348
|
$326,348
|
SHOHET, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
3R01CA166749-04S1
|
$13,734
|
$13,734
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
4R01CA166749-04
|
$318,913
|
$318,913
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-02
|
$669,859
|
$669,859
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Pharmacological modulation of epigenetic changes in AML
|
5R01CA102031-11
|
$342,107
|
$171,054
|
MARCUCCI, GUIDO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-33S1
|
$125,651
|
$6,283
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-33S2
|
$124,999
|
$6,250
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-33S3
|
$37,400
|
$1,870
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-33S4
|
$350,000
|
$17,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
4P30CA033572-33
|
$2,520,000
|
$126,000
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-12
|
$2,156,131
|
$258,736
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Self-Management and Support for Adolescents and Young Adults with Cancer
|
1R43CA206666-01A1
|
$224,911
|
$112,456
|
DONOVAN, ELIZABETH
|
BODIMOJO, INC
|
|
|
Molecular Mechanisms Regulating the Alternative Lengthening of Telomeres Pathway
|
1R01CA201446-01A1
|
$376,294
|
$376,294
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Developing a translational pipeline for NF1-mutant malignancies
|
1U01CA202943-01
|
$578,917
|
$578,917
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-18
|
$2,249,567
|
$269,948
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Pathogenesis and Treatment of NUT-Midline Carcinoma
|
4R01CA124633-09
|
$366,829
|
$366,829
|
FRENCH, CHRISTOPHER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation
|
4R01CA047006-29
|
$565,231
|
$282,616
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Epstein-Barr Virus LMP1-Mediated Oncogenecity
|
4R01CA085180-15
|
$762,316
|
$381,158
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
4R01CA170023-04
|
$393,163
|
$196,582
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Loss of Fractalkine Signaling Affects CNS Tumor Growth via Microglia Interactions
|
5F31CA196265-02
|
$29,633
|
$29,633
|
DORAND, RODNEY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S1
|
$20,833
|
$833
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S2
|
$60,000
|
$2,400
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S3
|
$118,406
|
$4,736
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Total relevant funding to Childhood Cancers for this search: $206,767,589
|
